Infectious SARS-CoV-2 in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection | Clinical Infectious Diseases | Oxford Academic

SARS-CoV-2 is evolving toward more efficient aerosol generation and loose-fitting masks provide significant but only modest source control. Therefore, until vaccination rates are very high, continued layered controls and tight-fitting masks and respirators will be necessary.

Oluwasanmi O Adenaiye, M.B.B.S., M.S, Jianyu Lai, B.Med., M.P.H, P Jacob Bueno de Mesquita, Ph.D, Filbert Hong, Ph.D, Somayeh Youssefi, Ph.D, Jennifer German, Ph.D, S-H Sheldon Tai, Ph.D, Barbara Albert, M.D., M.P.H, Maria Schanz, B.A., B.S, Stuart Weston, Ph.D, Jun Hang, Ph.D, Christian Fung, M.S, Hye Kyung Chung, Ph.D, Kristen K Coleman, Ph.D, Nicolae Sapoval, B.S, Todd Treangen, Ph.D, Irina Maljkovic Berry, Ph.D, Kristin Mullins, Ph.D, Matthew Frieman, Ph.D, Tianzhou Ma, Ph.D, Donald K Milton, M.D., Dr.P.H, for the University of Maryland StopCOVID Research Group, Infectious SARS-CoV-2 in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection, Clinical Infectious Diseases, 2021;, ciab797, https://doi.org/10.1093/cid/ciab797

Source: Infectious SARS-CoV-2 in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection | Clinical Infectious Diseases | Oxford Academic

Étiquettes: